Resumo (PT):
Abstract (EN):
In the past century, antibiotics revolutionized the way infectious diseases were treated, saving
millions of lives. However, bacteria, in particular these infectious, may develop antibiotic
resistance in such a way that the speed of development of new drugs does not follows the
development of resistance. Filamentous fungi have a vast, largely unexplored metabolome, giving
them great potential for novel antibiotic discovery. The One Strain MAny Compounds (OSMAC)
approach is a valuable tool in this regard and aims to vary culture conditions to obtain a wider
range of metabolites. In this study, five under-explored fungal species were used, aiming to
identify compounds with antibiotic or antibiofilm properties produced by them. They were grown
in different culture media, under deep fermentation for 7 and 14 days, with changing conditions
of aeration and agitation, and the resulting supernatants were tested for their antimicrobial
activity against Gram-positive and Gram-negative bacteria using the disk diffusion method. All
fungi grew on the different media and under the diverse process conditions. It was found that
Coprinopsis spilospora metabolites inhibited Staphylococcus aureus growth and demonstrated
antibiofilm properties. They reduced the biofilm in 30% in crystal violet staining, metabolic activity
by 82% in Alamar blue test, and viable cells counts by 96% in CFU counting. Co-culture and disk
diffusion test results also showed that this supernatant has a slight effect against Escherichia coli.
The pioneer results obtained in the present study highlight the relevance of bioprospection for
antibiotic discovery.
Language:
English
Type (Professor's evaluation):
Scientific